Summary for 4PS4
Entry DOI | 10.2210/pdb4ps4/pdb |
Related | 3L5W 3L5X |
Descriptor | M1295 LIGHT CHAIN, M1295 HEAVY CHAIN, Interleukin-13 (3 entities in total) |
Functional Keywords | immunoglobulin fold, alpha-helical bundle, cytokine, disulfide bond, glycoprotein, secreted, monoclonal antibody, immune system |
Biological source | Homo sapiens (human) More |
Total number of polymer chains | 3 |
Total formula weight | 60393.31 |
Authors | Teplyakov, A.,Obmolova, G.,Malia, T.,Gilliland, G.L. (deposition date: 2014-03-06, release date: 2014-03-19, Last modification date: 2024-10-09) |
Primary citation | Fransson, J.,Teplyakov, A.,Raghunathan, G.,Chi, E.,Cordier, W.,Dinh, T.,Feng, Y.,Giles-Komar, J.,Gilliland, G.,Lollo, B.,Malia, T.J.,Nishioka, W.,Obmolova, G.,Zhao, S.,Zhao, Y.,Swanson, R.V.,Almagro, J.C. Human Framework Adaptation of a Mouse Anti-Human Il-13 Antibody. J.Mol.Biol., 398:214-, 2010 Cited by PubMed Abstract: Humanization of a potent neutralizing mouse anti-human IL-13 antibody (m836) using a method called human framework adaptation (HFA) is reported. HFA consists of two steps: human framework selection (HFS) and specificity-determining residue optimization (SDRO). The HFS step involved generation of a library of m836 antigen binding sites combined with diverse human germline framework regions (FRs), which were selected based on structural and sequence similarities between mouse variable domains and a repertoire of human antibody germline genes. SDRO consisted of diversifying specificity-determining residues and selecting variants with improved affinity using phage display. HFS of m836 resulted in a 5-fold loss of affinity, whereas SDRO increased the affinity up to 100-fold compared to the HFS antibody. Crystal structures of Fabs in complex with IL-13 were obtained for m836, the HFS variant chosen for SDRO, and one of the highest-affinity SDRO variants. Analysis of the structures revealed that major conformational changes in FR-H1 and FR-H3 occurred after FR replacement, but none of them had an evident direct impact on residues in contact with IL-13. Instead, subtle changes affected the V(L)/V(H) (variable-light domain/variable-heavy domain) interface and were likely responsible for the 5-fold decreased affinity. After SDRO, increased affinity resulted mainly from rearrangements in hydrogen-bonding pattern at the antibody/antigen interface. Comparison with m836 putative germline genes suggested interesting analogies between natural affinity maturation and the engineering process that led to the potent HFA anti-human IL-13 antibody. PubMed: 20226193DOI: 10.1016/J.JMB.2010.03.004 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (2.8 Å) |
Structure validation
Download full validation report